Furthermore, dysfunction of DDX3 is involved in the progression of various cancers, including hepatocellular carcinoma 18, breast cancer 19, lung cancer 20, melanoma 21, as well as pancreatic cancer 22, suggesting investigations into the function of DDX3X might provide a novel strategy for cancer treatment. This evidence concerns the gene DDX3X and breast carcinoma.